Overlapping yet distinct spatiomolecular profiles across mood disorders and biological sex in the human prefrontal cortex
Authors:
- Jacqueline R. ThompsonJTJacqueline R. Thompson
- Seyun OhSOSeyun Oh
- Sarah E. MaguireSMSarah E. Maguire
- Svitlana V. BachSBSvitlana V. Bach
- Bernard J. MulveyBMBernard J. Mulvey
- Geo PerteaGPGeo Pertea
- Madeline R. AbramsonMAMadeline R. Abramson
- Ryan A. MillerRMRyan A. Miller
- Sang Ho KwonSKSang Ho Kwon
- Madhavi TippaniMTMadhavi Tippani
- Madeline R. ValentineMVMadeline R. Valentine
- Amy Deep-SoboslayADAmy Deep-Soboslay
Preprint
Abstract
Major depressive disorder (MDD) and bipolar disorder (BD) exhibit both overlapping and distinct clinical features, including sex differences in prevalence and symptomatology, but how these similarities and differences are reflected at the molecular and cellular level in the human brain remains poorly understood. Here, we applied spatial transcriptomics to the human dorsolateral prefrontal cortex from individuals with MDD, BD, and neurotypical controls to resolve molecular programs associated with diagnosis and biological sex. Our analysis revealed sex- and diagnosis-specific differences across white matter, the neurovascular unit (NVU), and neuronal compartments. Within white matter, we identified female-specific survival-response programs shared in both MDD and BD, and divergent myelin-related gene expression patterns across disorders ( CLDN11 , CNDP1 ). Within the NVU, transcriptional evidence of impaired vascular integrity was accompanied by astrocytic response profiles in females with MDD and males with BD, with inflammatory responses further evident in females with MDD ( IFITM3 , CEBPD , IL1R1 ). In donors with BD of both sexes and in females with MDD, inhibitory neurons exhibited impaired neuropeptide expression ( SST , CORT , CRH ). Integration with donor genotype information highlighted that genetic risk for mood disorders influences MAPK3 expression, implicating altered ERK signaling, which was further supported by disorder-associated changes in Ras/MEK/ERK pathway components in neurons ( MAPK3, DUSP6 , RASD1 , ELK1 ). Together, these findings reveal coordinated, cell type- and spatial domain-specific molecular programs that distinguish shared and disorder-specific transcriptomic changes across mood disorders in a sex-dependent manner.Keywords
This publication has 251 references indexed in Scilit:
- Oligodendrocyte‐Targeted SGK1.1 Inhibition Alleviates White Matter Injury and Cognitive Impairment in Alzheimer's Disease via Modulation of HDAC2 PhosphorylationCNS Neuroscience & Therapeutics, 2026
- Specificity of Polygenic Scores for Psychiatric Disorders Beyond Transdiagnostic Genetic RiskJAMA Network Open, 2026
- Astrocytes, via RTP801, contribute to cognitive decline by disrupting GABAergic‐regulated connectivity and driving neuroinflammation in an Alzheimer's disease mouse modelAlzheimer's & Dementia, 2025
- Polygenic Scores and Mood Disorder Onsets in the Context of Family History and Early PsychopathologyJAMA Network Open, 2025
- Inhibition of IFITM3 in cerebrovascular endothelium alleviates Alzheimer's‐related phenotypesAlzheimer's & Dementia, 2025
- Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation Across Mental DisordersJAMA Network Open, 2024
- Diagnostic Specificity and Association With Cognition of Molecular Alterations in Prefrontal Somatostatin Neurons in SchizophreniaJAMA Psychiatry, 2023
- Unraveling the mystery of white matter in depression: A translational perspective on recent advancesBrain and Behavior, 2022
- Risk of Early-Onset Depression Associated With Polygenic Liability, Parental Psychiatric History, and Socioeconomic StatusJAMA Psychiatry, 2021
- Rat brain vascular distribution of interleukin‐1 type‐1 receptor immunoreactivity: Relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuliJournal of Comparative Neurology, 2004